作者: John L.R. Rubenstein , Maike Sander , Roger A. Pedersen , Michael S. German , Juanito J. Meneses
DOI:
关键词: Depression (differential diagnoses) 、 Internal medicine 、 Biology 、 Diabetes mellitus 、 Genetically modified mouse 、 Gene 、 Function (biology) 、 Endocrinology 、 Obesity
摘要: The present invention features mouse models for Nkx-2.2 gene function and Nkx-6.1 function, wherein the transgenic is characterized by having a defect in or (where, because acts upstream of Nkx-6.1, affects function) decreased number insulin-producing cells relative to normal mouse. Where contains further serotonin-producing mice may be either homozygous heterozygous defect.